NFKB1 and colorectal cancer: Constitutive NFκB activation, along with the associated increased expression of anti-apoptotic genes, is implicated in the resistance of tumor cells to chemotherapy and radiotherapy while inhibition of NFκB activity sensitizes prostate and colorectal cancer cells to chemotherapy-induced apoptosis [79].